Market Research Logo

Global Thalassemia Drugs Market 2018-2022

Global Thalassemia Drugs Market 2018-2022

About Thalassemia

Thalassemia is an inherited blood disorder that predominantly affects the iron levels in the red blood cells. There are two types of drugs for the treatment of thalassemia, alpha thalassemia drugs and beta thalassemia drugs.

Technavio’s analysts forecast the Global Thalassemia Drugs Market to grow at a CAGR of 9.9% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the thalassemia drugs market. To calculate the market size, the report considers the revenue generated from the retail sales of alpha thalassemia drugs and beta thalassemia drugs across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, thalassemia drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • ApoPharma
  • Fresenius Kabi
  • Novartis
  • Pfizer
  • Teva Pharmaceutical Industries
Market driver
  • Increasing prevalence of thalassemia
  • For a full, detailed list, view our report
Market challenge
  • High expense of treatment
  • For a full, detailed list, view our report
Market trend
  • Rising disease awareness programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global thalassemia drugs market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global thalassemia drugs market – Market size and forecast 2017-2022 ($ mn)
      • Table Global thalassemia drugs market – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase 2018
    • Table Key clinical trial candidates of thalassemia
  • Market segmentation by category
    • Segmentation by category
      • Table Global thalassemia drugs market – Market share by category 2017-2022 (%)
    • Comparison by category
      • Table Comparison by category
    • Alpha thalassemia drugs – Market size and forecast 2017-2022
      • Table Global alpha thalassemia drugs market – Market size and forecast 2017-2022 ($ mn)
      • Table Global alpha thalassemia drugs market – Year-over-year growth 2018-2022 (%)
    • Beta thalassemia drugs – Market size and forecast 2017-2022
      • Table Global beta thalassemia drugs market – Market size and forecast 2017-2022 ($ mn)
      • Table Global beta thalassemia drugs market – Year-over-year growth 2018-2022 (%)
    • Market opportunity by category
      • Table Market opportunity by category
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global thalassemia drugs market – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Rising disease awareness programs
    • Rising scope for gene therapy
    • Increasing pharmaceutical R&D spending
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ApoPharma
      • Table ApoPharma – Overview
      • Table ApoPharma – Business segments
      • Table ApoPharma – Organizational developments
      • Table ApoPharma – Geographic focus
      • Table ApoPharma – Segment focus
      • Table ApoPharma – Key offerings
      • Table ApoPharma – Key customers
    • Fresenius Kabi
      • Table Fresenius Kabi – Overview
      • Table Fresenius Kabi – Business segments
      • Table Fresenius Kabi – Organizational developments
      • Table Fresenius Kabi – Geographic focus
      • Table Fresenius Kabi – Segment focus
      • Table Fresenius Kabi – Key offerings
      • Table Fresenius Kabi – Key customers
    • Novartis
      • Table Novartis – Overview
      • Table Novartis – Business segments
      • Table Novartis – Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis – Segment focus
      • Table Novartis – Key offerings
      • Table Novartis – Key customers
    • Pfizer
      • Table Pfizer – Overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
      • Table Pfizer – Key customers
    • Teva Pharmaceutical Industries
      • Table Teva Pharmaceutical Industries – Overview
      • Table Teva Pharmaceutical Industries – Business segments
      • Table Teva Pharmaceutical Industries – Organizational developments
      • Table Teva Pharmaceutical Industries – Geographic focus
      • Table Teva Pharmaceutical Industries – Segment focus
      • Table Teva Pharmaceutical Industries – Key offerings
      • Table Teva Pharmaceutical Industries – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report